• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Emergency Classics

Mild hypothermia improves neurological outcome after cardiac arrest [Classics Series]

byAndrew Cheung, MD MBA
December 3, 2013
in Emergency Classics, General Medicine Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Initiation of hypothermia protocol for 24 hours after a cardiac arrest significantly improved neurological outcome in surviving patients

2. Patients who underwent the hypothermia protocol had a significantly lower mortality rate at 6 months

3. There were no significant differences in adverse outcomes between the two groups

Original date of publication: February 21, 2002

Study Rundown: This landmark trial demonstrated that inducing mild hypothermia early in patients who suffered a cardiac arrest reduces permanent neurological damage secondary to global cerebral ischemia. The subjects who underwent cooling within 4 hours of cardiac arrest experienced better neurological outcomes as well as a lower mortality rate 6 months out from the event (RR 0.74; 95%CI 0.58-0.95). There was no difference in adverse outcomes between the two groups in the first 7 days after the event, although data showed a trend toward susceptibility to infections in the hypothermia group.

The subjects in the normothermia group did have a higher prevalence of diabetes mellitus and coronary artery disease compared to the hypothermia group, however the significance of the results did not change when these differences were controlled for. While the study was not blinded with regards to implementation of therapy, neurological assessment 6 months after therapy was blinded. The time to initiation of the hypothermia protocol also varied within the group, ranging from 61 to 192 minutes, with a median of 105 minutes. It would be interesting to assess whether the time to initiation of cooling made a difference in neurological outcomes 6 months later. In summary, the patients who underwent cooling within 4 hours after a cardiac arrest from ventricular fibrillation showed a significantly higher rate of favorable neurological outcome compared to the patients who underwent standard normothermia treatment.

RELATED REPORTS

Extracorporeal CPR and conventional CPR similarly improve cardiac arrest survival

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

#VisualAbstract: Smartphone dispatch of volunteer responders may not increase bystander use of automated external defibrillator in out-of-hospital cardiac arrest

Click to read the study in NEJM

Click to read an accompanying editorial in NEJM

In-Depth [randomized, controlled study]: This 2002 study published in NEJM was a randomized controlled trial with blinded assessment that randomly assigned 275 patients coming in to the ED with a cardiac arrest due to ventricular fibrillation to either standard normothermia or to a mild hypothermia protocol. Eligible subjects were patients between 18-75 years of age who had suffered a cardiac arrest from ventricular fibrillation and had an estimated 5-15 minute delay before cardiac resuscitation was started. Patients with coagulopathies, pregnancy, terminal illness, other causes of cardiac arrest, in a coma state at baseline, or hypotensive or hypoxic for 30 min or 15 min, respectively, prior to randomization were excluded. The group assigned to mild hypothermia treatment was cooled to a target temperature between 32°C to 34°C with the use of an external cooling device and ice packs, if necessary. The temperature was maintained at 32°C to 34°C for 24 hours and was followed by passive rewarming, which averaged out to an 8-hour period.

The study demonstrated that the group assigned to mild hypothermia treatment had a significantly higher rate of favorable neurological outcome (as assessed blindly 6 months later via the Pittsburgh cerebral performance scale) than the group that underwent standard normothermia treatment (55% vs. 39%, RR 1.40; 95%CI 1.08-1.81). The hypothermia group also had a significantly lower 6-month mortality rate compared to the normothermia group (RR 0.74; 95%CI 0.58-0.95). There were no significant differences in complication rates in the first 7 days after randomization between the two groups.

By Milana Bogorodskaya and Andrew Cheung, M.D.

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: cardiac arresthypothermia
Previous Post

2 Minute Medicine Rewind November 24 – December 1, 2013

Next Post

The SAVE trial: Captopril after acute MI reduces mortality and morbidity [Classics Series]

RelatedReports

Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest
Cardiology

Extracorporeal CPR and conventional CPR similarly improve cardiac arrest survival

February 2, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

March 14, 2023
#VisualAbstract: Smartphone dispatch of volunteer responders may not increase bystander use of automated external defibrillator in out-of-hospital cardiac arrest
StudyGraphics

#VisualAbstract: Smartphone dispatch of volunteer responders may not increase bystander use of automated external defibrillator in out-of-hospital cardiac arrest

December 21, 2022
Metronome use linked to rate optimization in pediatric CPR
Cardiology

Smartphone volunteer app dispatches may increase Automated External Defibrillator use

December 16, 2022
Next Post

The SAVE trial: Captopril after acute MI reduces mortality and morbidity [Classics Series]

Assisted conception not associated with increased pediatric cancer risk

Rates of multiple births and multiple embryo IVF procedures have decreased in the past decade

Imaging biomarkers may improve prediction of aortic valve stenosis

Imaging biomarkers may improve prediction of aortic valve stenosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means
  • Combination doxycycline and azithromycin therapy effective in treating severe scrub typhus
  • Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options